NCT00562120 - A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Allergic Rhinitis

Interventions

DRUG

Placebo

A single oral dose of Placebo is dosed during the study in order to ascertain the effect of placebo on measures and in order to maintain the blind of the other drugs.

DRUG

Allegra

A single oral dose of Allegra is dosed to subjects in combination with PF-03654746.

DRUG

Allegra-D

A single oral dose of Allegra-D is dosed to subjects as an active comparator.

DRUG

PF-03654746

A single oral dose of PF-03654746 is the investigational drug being studied.

Trial Locations (1)

68131

Pfizer Investigational Site, Omaha